Damian Wild

16PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurosciences not elsewhere classifiedMolecular targetsTime-series analysisMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 21, 2026
68Ga-DOTA-exendin-4 PET/CT for Insulinoma Localization in Patients with Negative or Inconclusive Conventional Imaging.

|May 04, 2026
Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.

|Mar 24, 2026
Increased progression free survival with radiolabelled somatostatin receptor antagonist versus standard peptide receptor radionuclide therapy in patients with somatostatin receptor positive tumours.

Abdulrafee Mushaweh, Christopher Eigler, Lisa McDougall

|Mar 17, 2026
Temporal trends in pretest probability and normal scan rates in myocardial perfusion imaging: a 24-year experience from a Swiss tertiary referral center (between 2000 and 2024).

Simon M Frey, Igor G Schneider, Ann-Sophie Otto

|Aug 01, 2025
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study.

Matthias Hepprich, Christina Romberg, Jonathan Mudry

|Jul 24, 2025
Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors.

Andrea Widmer, Urs Zumsteg, Gabor Szinnai

Pageof 3

Frequent Collaborators

4 joint publications

Emanuel Christ

2 joint publications

Philip Haaf

2 joint publications

Simon M Frey

2 joint publications

Julie Refardt